Photodynamic Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global Photodynamic Therapy (PDT) market is experiencing a transformational shift with manufacturers increasingly focusing on the launch of phototherapy drug-device combinations. This strategic move is creating significant growth opportunities and reshaping the landscape of dermatology treatments.
Unlocking Innovation in Dermatology
Traditionally, the PDT market was dominated by photosensitizer drugs, but market players are now enhancing the complexity of drug molecules to prevent replication by competitors. Similar to the drug development field, players in the photodynamic therapy market are pioneering innovative routes to market through the launch of combination products that involve a photosensitizer drug and a device.
Recent market discussions have highlighted dermatology as a highly fragmented sector with substantial unmet needs and limited innovations. In response, companies are exploring inorganic routes such as acquisitions, as exemplified by Sun Pharmaceutical's acquisition of DUSA for US$ 200 Mn. This strategic move allowed Sun Pharmaceutical to access DUSA's patented drug-device combination Levulan, which is instrumental in photodynamic therapy for treating Actinic Keratosis (AK), psoriasis, and acne.
Driving Market Growth
The entry of market players into the drug-device combination segment, coupled with increasing research in light therapy devices, and the widespread adoption of photosensitizer drugs for photodynamic therapy, are all contributing factors expected to propel the photodynamic therapy market.
Dynamic Epidemiology Fuels Growth
The prevalence of various skin diseases, including actinic keratosis, psoriasis, acne, rosacea, and others, varies across the globe, depending on genetic makeup, skin type, and lifestyle factors. With Australia reporting the highest prevalence of actinic keratosis and the U.S. grappling with a significant psoriasis burden, the growing incidence of these skin disorders is expected to drive revenue growth in the photodynamic therapy market.
Limited Competition Spurs Innovation
Photodynamic therapy has emerged as one of the most successful treatment options for actinic keratosis, skin diseases, and basal cell carcinomas. Physicians often prescribe photodynamic therapy when cryotherapy or topical treatments prove ineffective. Key products such as LEVULAN KERASTICK by Sun Pharmaceutical, Ameluz by Biofrontera, and Metvix by Galderma currently dominate the market. This limited competition creates an opportunity for other dermatology product manufacturers to introduce cost-effective phototherapy solutions, thereby strengthening their foothold in the market.
Competitive Analysis
Key players in the photodynamic therapy market include Sun Pharmaceutical Industries Ltd., Galderma SA, Biofrontera AG, Allergan Plc., Hologic, Inc., and Quest PharmaTech Inc., offering a comprehensive range of photosensitizer drugs and therapy devices.
Market Segmentation
The latest report on the photodynamic therapy market presents a comprehensive taxonomy, providing a detailed breakdown of this dynamic industry based on product type, application, end users, and geographical regions. This segmentation strategy offers a clear understanding of the various facets of the photodynamic therapy market.
Product Type
• Photosensitizer Drugs
1. Hematoporphyrin Derivative (HpD)
2. Aminolevulinic Acid (ALA)
3. Benzoporphyrin Derivatives
4. Texaphyrins
5. Chlorins
6. Dyes
• Devices
1. Disposable Fiber Optic Light Delivery Devices
2. Diode Lasers
Applications
Photodynamic therapy is a versatile approach with applications in various medical fields. The major applications include:
• Basal Cell Carcinoma
• Actinic Keratosis
• Other Applications
End Users
The photodynamic therapy market caters to a diverse range of end users, including:
• Hospitals
• Clinics
• Dermatology Centers
• Ambulatory Surgical Centers
• Research Institutes
Geographical Regions
The photodynamic therapy market has been thoroughly analyzed across the following regions:
• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa (MEA)
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
- 1. Executive Summary
- 1.1. Global Photodynamic Therapy Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global Photodynamic Therapy Market Outlook, 2018 – 2031
- 3.1. Global Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Photosensitizer Drugs
- 3.1.1.1.1. Hematoporphyrin derivative (HpD)
- 3.1.1.1.2. Aminolevulinic acid (ALA)
- 3.1.1.1.3. Benzoporphyrin derivative (BPD)
- 3.1.1.1.4. Texaphyrins
- 3.1.1.1.5. Chlorins
- 3.1.1.1.6. Dyes
- 3.1.1.2. Devices
- 3.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
- 3.1.1.2.2. Diode Laser
- 3.2. Global Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Basal Cell Carcinoma
- 3.2.1.2. Actinic Keratosis
- 3.2.1.3. Others
- 3.2.1.3.1. Psoriasis
- 3.2.1.3.2. Acne
- 3.3. Global Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Hospitals
- 3.3.1.2. Private Dermatology Clinics
- 3.3.1.3. Laser Therapy Centers
- 3.3.1.4. Cancer Treatment Centers
- 3.3.1.5. Spas and Rejuvenation Centers
- 3.4. Global Photodynamic Therapy Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
- 3.4.1. Key Highlights
- 3.4.1.1. North America
- 3.4.1.2. Europe
- 3.4.1.3. Asia Pacific
- 3.4.1.4. Latin America
- 3.4.1.5. Middle East & Africa
- 4. North America Photodynamic Therapy Market Outlook, 2018 – 2031
- 4.1. North America Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Photosensitizer Drugs
- 4.1.1.1.1. Hematoporphyrin derivative (HpD)
- 4.1.1.1.2. Aminolevulinic acid (ALA)
- 4.1.1.1.3. Benzoporphyrin derivative (BPD)
- 4.1.1.1.4. Texaphyrins
- 4.1.1.1.5. Chlorins
- 4.1.1.1.6. Dyes
- 4.1.1.2. Devices
- 4.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
- 4.1.1.2.2. Diode Laser
- 4.2. North America Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Basal Cell Carcinoma
- 4.2.1.2. Actinic Keratosis
- 4.2.1.3. Others
- 4.2.1.3.1. Psoriasis
- 4.2.1.3.2. Acne
- 4.3. North America Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Hospitals
- 4.3.1.2. Private Dermatology Clinics
- 4.3.1.3. Laser Therapy Centers
- 4.3.1.4. Cancer Treatment Centers
- 4.3.1.5. Spas and Rejuvenation Centers
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
- 4.4. North America Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. U.S. Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 4.4.1.2. U.S. Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 4.4.1.3. U.S. Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 4.4.1.4. Canada Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 4.4.1.5. Canada Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 4.4.1.6. Canada Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe Photodynamic Therapy Market Outlook, 2018 – 2031
- 5.1. Europe Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Photosensitizer Drugs
- 5.1.1.1.1. Hematoporphyrin derivative (HpD)
- 5.1.1.1.2. Aminolevulinic acid (ALA)
- 5.1.1.1.3. Benzoporphyrin derivative (BPD)
- 5.1.1.1.4. Texaphyrins
- 5.1.1.1.5. Chlorins
- 5.1.1.1.6. Dyes
- 5.1.1.2. Devices
- 5.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
- 5.1.1.2.2. Diode Laser
- 5.2. Europe Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Basal Cell Carcinoma
- 5.2.1.2. Actinic Keratosis
- 5.2.1.3. Others
- 5.2.1.3.1. Psoriasis
- 5.2.1.3.2. Acne
- 5.3. Europe Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Hospitals
- 5.3.1.2. Private Dermatology Clinics
- 5.3.1.3. Laser Therapy Centers
- 5.3.1.4. Cancer Treatment Centers
- 5.3.1.5. Spas and Rejuvenation Centers
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
- 5.4. Europe Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Germany Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.2. Germany Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.3. Germany Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1.4. U.K. Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.5. U.K. Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.6. U.K. Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1.7. France Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.8. France Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.9. France Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1.10. Italy Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.11. Italy Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.12. Italy Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1.13. Turkey Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.14. Turkey Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.15. Turkey Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1.16. Russia Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.17. Russia Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.18. Russia Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.1.19. Rest of Europe Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.4.1.20. Rest of Europe Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 5.4.1.21. Rest of Europe Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific Photodynamic Therapy Market Outlook, 2018 – 2031
- 6.1. Asia Pacific Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Photosensitizer Drugs
- 6.1.1.1.1. Hematoporphyrin derivative (HpD)
- 6.1.1.1.2. Aminolevulinic acid (ALA)
- 6.1.1.1.3. Benzoporphyrin derivative (BPD)
- 6.1.1.1.4. Texaphyrins
- 6.1.1.1.5. Chlorins
- 6.1.1.1.6. Dyes
- 6.1.1.2. Devices
- 6.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
- 6.1.1.2.2. Diode Laser
- 6.2. Asia Pacific Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Basal Cell Carcinoma
- 6.2.1.2. Actinic Keratosis
- 6.2.1.3. Others
- 6.2.1.3.1. Psoriasis
- 6.2.1.3.2. Acne
- 6.3. Asia Pacific Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Hospitals
- 6.3.1.2. Private Dermatology Clinics
- 6.3.1.3. Laser Therapy Centers
- 6.3.1.4. Cancer Treatment Centers
- 6.3.1.5. Spas and Rejuvenation Centers
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
- 6.4. Asia Pacific Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. China Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.4.1.2. China Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 6.4.1.3. China Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 6.4.1.4. Japan Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.4.1.5. Japan Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 6.4.1.6. Japan Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 6.4.1.7. South Korea Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.4.1.8. South Korea Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 6.4.1.9. South Korea Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 6.4.1.10. India Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.4.1.11. India Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 6.4.1.12. India Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 6.4.1.13. Southeast Asia Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.4.1.14. Southeast Asia Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 6.4.1.15. Southeast Asia Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 6.4.1.16. Rest of Asia Pacific Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.4.1.17. Rest of Asia Pacific Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 6.4.1.18. Rest of Asia Pacific Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America Photodynamic Therapy Market Outlook, 2018 – 2031
- 7.1. Latin America Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Photosensitizer Drugs
- 7.1.1.1.1. Hematoporphyrin derivative (HpD)
- 7.1.1.1.2. Aminolevulinic acid (ALA)
- 7.1.1.1.3. Benzoporphyrin derivative (BPD)
- 7.1.1.1.4. Texaphyrins
- 7.1.1.1.5. Chlorins
- 7.1.1.1.6. Dyes
- 7.1.1.2. Devices
- 7.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
- 7.1.1.2.2. Diode Laser
- 7.2. Latin America Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 7.2.1.1. Basal Cell Carcinoma
- 7.2.1.2. Actinic Keratosis
- 7.2.1.3. Others
- 7.2.1.3.1. Psoriasis
- 7.2.1.3.2. Acne
- 7.3. Latin America Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Hospitals
- 7.3.1.2. Private Dermatology Clinics
- 7.3.1.3. Laser Therapy Centers
- 7.3.1.4. Cancer Treatment Centers
- 7.3.1.5. Spas and Rejuvenation Centers
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
- 7.4. Latin America Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. Brazil Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.4.1.2. Brazil Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 7.4.1.3. Brazil Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 7.4.1.4. Mexico Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.4.1.5. Mexico Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 7.4.1.6. Mexico Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 7.4.1.7. Argentina Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.4.1.8. Argentina Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 7.4.1.9. Argentina Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 7.4.1.10. Rest of Latin America Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.4.1.11. Rest of Latin America Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 7.4.1.12. Rest of Latin America Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa Photodynamic Therapy Market Outlook, 2018 – 2031
- 8.1. Middle East & Africa Photodynamic Therapy Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Photosensitizer Drugs
- 8.1.1.1.1. Hematoporphyrin derivative (HpD)
- 8.1.1.1.2. Aminolevulinic acid (ALA)
- 8.1.1.1.3. Benzoporphyrin derivative (BPD)
- 8.1.1.1.4. Texaphyrins
- 8.1.1.1.5. Chlorins
- 8.1.1.1.6. Dyes
- 8.1.1.2. Devices
- 8.1.1.2.1. Disposable Fiberoptic Light Delivery Devices
- 8.1.1.2.2. Diode Laser
- 8.2. Middle East & Africa Photodynamic Therapy Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Basal Cell Carcinoma
- 8.2.1.2. Actinic Keratosis
- 8.2.1.3. Others
- 8.2.1.3.1. Psoriasis
- 8.2.1.3.2. Acne
- 8.3. Middle East & Africa Photodynamic Therapy Market Outlook, by End User, Value (US$ Bn), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Hospitals
- 8.3.1.2. Private Dermatology Clinics
- 8.3.1.3. Laser Therapy Centers
- 8.3.1.4. Cancer Treatment Centers
- 8.3.1.5. Spas and Rejuvenation Centers
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
- 8.4. Middle East & Africa Photodynamic Therapy Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. GCC Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.4.1.2. GCC Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 8.4.1.3. GCC Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 8.4.1.4. South Africa Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.4.1.5. South Africa Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 8.4.1.6. South Africa Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 8.4.1.7. Egypt Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.4.1.8. Egypt Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 8.4.1.9. Egypt Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 8.4.1.10. Nigeria Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.4.1.11. Nigeria Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 8.4.1.12. Nigeria Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 8.4.1.13. Rest of Middle East & Africa Photodynamic Therapy Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.4.1.14. Rest of Middle East & Africa Photodynamic Therapy Market by Application, Value (US$ Bn), 2018 – 2031
- 8.4.1.15. Rest of Middle East & Africa Photodynamic Therapy Market by End User, Value (US$ Bn), 2018 – 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. By Distribution Channel vs by Application Heat map
- 9.2. Manufacturer vs by Application Heatmap
- 9.3. Company Market Share Analysis, 2023
- 9.4. Competitive Dashboard
- 9.5. Company Profiles
- 9.5.1. Galderma S.A.
- 9.5.1.1. Company Overview
- 9.5.1.2. Product Portfolio
- 9.5.1.3. Financial Overview
- 9.5.1.4. Business Strategies and Development
- 9.5.2. Sun Pharmaceutical Industries Ltd.
- 9.5.2.1. Company Overview
- 9.5.2.2. Product Portfolio
- 9.5.2.3. Financial Overview
- 9.5.2.4. Business Strategies and Development
- 9.5.3. Biofrontera
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Portfolio
- 9.5.3.3. Financial Overview
- 9.5.3.4. Business Strategies and Development
- 9.5.4. Novartis AG
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Portfolio
- 9.5.4.3. Financial Overview
- 9.5.4.4. Business Strategies and Development
- 9.5.5. Allergan Plc
- 9.5.5.1. Company Overview
- 9.5.5.2. Product Portfolio
- 9.5.5.3. Financial Overview
- 9.5.5.4. Business Strategies and Development
- 9.5.6. Quest Pharmatech, Inc.
- 9.5.6.1. Company Overview
- 9.5.6.2. Product Portfolio
- 9.5.6.3. Financial Overview
- 9.5.6.4. Business Strategies and Development
- 9.5.7. Valeant Pharmaceuticals International, Inc.
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Portfolio
- 9.5.7.3. Financial Overview
- 9.5.7.4. Business Strategies and Development
- 9.5.8. Hologic, Inc. (Cynosure Inc.)
- 9.5.8.1. Company Overview
- 9.5.8.2. Product Portfolio
- 9.5.8.3. Financial Overview
- 9.5.8.4. Business Strategies and Development
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook